Oliver Luxxe Assets LLC Has $1.97 Million Stake in Envista Holdings Corporation $NVST

Oliver Luxxe Assets LLC trimmed its stake in Envista Holdings Corporation (NYSE:NVST) by 19.6% in the second quarter, Holdings Channel.com reports. The firm owned 74,749 shares of the company’s stock after selling 18,183 shares during the quarter. Oliver Luxxe Assets LLC’s holdings in Envista were worth $1,970,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the stock. Parallel Advisors LLC increased its stake in Envista by 13.1% in the 4th quarter. Parallel Advisors LLC now owns 3,175 shares of the company’s stock valued at $69,000 after buying an additional 367 shares during the period. Bank of Montreal Can increased its position in Envista by 1.4% in the 4th quarter. Bank of Montreal Can now owns 26,178 shares of the company’s stock worth $568,000 after purchasing an additional 372 shares during the last quarter. Sepio Capital LP increased its position in Envista by 1.2% in the 4th quarter. Sepio Capital LP now owns 31,632 shares of the company’s stock worth $687,000 after purchasing an additional 374 shares during the last quarter. Deutsche Bank AG raised its stake in shares of Envista by 2.9% during the 4th quarter. Deutsche Bank AG now owns 17,412 shares of the company’s stock worth $378,000 after purchasing an additional 484 shares in the last quarter. Finally, State of Michigan Retirement System raised its stake in shares of Envista by 1.5% during the 1st quarter. State of Michigan Retirement System now owns 39,463 shares of the company’s stock worth $1,001,000 after purchasing an additional 600 shares in the last quarter.

Envista Price Performance

Shares of Envista stock opened at $28.22 on Friday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.43 and a quick ratio of 2.06. The company has a market cap of $4.59 billion, a PE ratio of 48.65, a price-to-earnings-growth ratio of 1.49 and a beta of 0.86. The firm has a fifty day moving average price of $26.03 and a two-hundred day moving average price of $26.02. Envista Holdings Corporation has a fifty-two week low of $18.77 and a fifty-two week high of $30.42.

Envista (NYSE:NVST) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.07. The company had revenue of $730.50 million for the quarter, compared to the consensus estimate of $716.11 million. Envista had a net margin of 3.33% and a return on equity of 7.88%. The business’s revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.26 EPS. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. Analysts expect that Envista Holdings Corporation will post 1.53 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on NVST. Barclays cut their price objective on shares of Envista from $34.00 to $32.00 and set an “overweight” rating on the stock in a research report on Thursday, June 11th. Piper Sandler reissued a “neutral” rating and issued a $28.00 target price (up from $26.00) on shares of Envista in a research report on Thursday. Evercore restated an “outperform” rating and set a $33.00 price target on shares of Envista in a research note on Thursday, May 7th. JPMorgan Chase & Co. raised their price target on shares of Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Finally, Weiss Ratings raised shares of Envista from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday. Six equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $29.31.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.